\
&
Contact us
Published on | 2 years ago
ProgrammesThe Joint Transnational Call is launched in the framework of the European Partnership Water4All and supports research and innovation projects to improve water security in the long term. In line with the strategic objectives of Water4All, the results should contribute to the implementation of evidence-based, global, EU and national water management policies and strategies, including the Green Deal, the Water Framework Directive (WFD), Just Transition and the Water Action Agenda for UN Sustainable Development Goals.
The context for the general call topics is described in Theme II of the Water4All Strategic Research and Innovation Agenda (SRIA), “Water for ecosystems and biodiversity”.
Information from the partnership on this call can be found here.
Relevant information on this call from Vlaanderen/VLAIO can be found here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.